Skip to main content

Table 2 Passing-Bablok analysis between laboratories and reference center (LAB 1) for each component

From: A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease

 

LAB 2

LAB 3

LAB 4

LAB 5

LAB 6

LAB 7

LAB 10

LAB 11

α2-macroglobulin

        

   Intercept (alpha)

-0.05

0.13

-0.10

0.22

0.07

0.19

0.13

0.00

   Slope (beta)

0.99

1.04

1.08

0.97

1

0.98

0.94

1.24

   Pair out of bounds (n)

0

7

3

8

1

5

3

11

Haptoglobin

        

   Intercept (alpha)

0.01

0.02

0.01

0.02

-0.05

0.01

0.02

0.02

   Slope (beta)

1

0.98

1

0.94

0.99

1.04

1

0.94

   Pair out of bounds (n)

0

0

2

2

1

0

0

2

Apolipoprotein A1

        

   Intercept (alpha)

0.25

0.02

0.11

-0.04

0.00

-0.04

-0.08

-0.04

   Slope (beta)

0.85

0.99

0.87

0.81

1

0.90

1.12

1

   Pair out of bounds (n)

0

0

0

17

0

4

0

0

Total bilirubin

        

   Intercept (alpha)

-2.52

-0.50

-0.03

3.97

0.28

0.05

-5.23

0.30

   Slope (beta)

0.95

1

0.58

0.92

0.99

1.18

2.34

0.92

   Pair out of bounds (n)

4

1

6

0

1

4

3

3

Transaminases – ALT

        

   Intercept (alpha)

15.33

15.00

-0.83

-1.78

0.91

2.99

2.38

-3.33

   Slope (beta)

0.98

1

1.04

0.85

0.86

0.79

0.75

1.06

   Pair out of bounds (n)

18

19

1

19

12

16

19

1

γ-glutamyl transpeptidase

        

   Intercept (alpha)

7.54

2.48

0.83

10.69

1.56

-0.84

4.72

7.40

   Slope (beta)

1.26

1.25

1.01

0.74

1.06

0.90

0.73

1.04

   Pair out of bounds (n)

18

20

1

10

4

4

16

12